The Health Research Board (HRB) Impact Award 2023 was awarded to ADAPT Principal Investigator and TCD Professor Orla Hardiman for her outstanding contributions to research that have positively informed policy and practice impacting both the care and well-being of patients living with neurodegenerative conditions and their families.
Prof. Orla Hardiman is a Professor of Neurology at Trinity College, Consultant Neurologist at Beaumont Hospital, and National Clinical Lead, Neurology, at the Health Services Executive. She is also the Principal Investigator (PI) for ADAPT’s research programme Precision ALS (PALS). PALS is a €10 million research programme involving researchers at ADAPT and FutureNeuro along with the TRICALS Consortium, Europe’s largest ALS research initiative. Actively participating, are national and International industry partners and charities including patient organisations. PALS will provide an innovative and interactive platform for all clinical research in ALS across Europe, that will then harness artificial intelligence (AI) to analyse large amounts of data. The programme cements Ireland’s world leadership position in MND research and Artificial Intelligence, and will generate scores of new jobs in clinical and data science research, new technologies and drug development for Ireland.
Prof. Hardiman’s research is funded by Science Foundation Ireland, the Health Research Board, The American Centre for Disease Control, The American ALS Association, the British MND Association, the Irish MND Association, and the charity Research Motor Neuron.
